| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.18 | 7e-08 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.18 | 9e-08 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-06 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.15 | 1e-06 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | 0.17 | 2e-06 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-06 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-06 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.16 | 3e-06 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.16 | 4e-06 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.15 | 5e-06 |